You can buy or sell ARMP and other stocks, options, ETFs, and crypto commission-free!
Armata Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company focused on the development of bacteriophage therapeutics for antibiotic-resistant infections using its proprietary bacteriophage-based technology. Its product candidate is the AP-SA01 that targets Staphylococcus aureus, including multidrug-resistant strains. Read More The company was founded on May 9, 2019 and is headquartered in Los Angeles, CA.
Los Angeles, California
52 Week High
52 Week Low
Seeking AlphaMay 28
ARMP, BIOC among top gainers
Armata Pharmaceuticals (NYSEMKT:ARMP) +28% on encouraging AP-PA01 data. Biocept (NASDAQ:BIOC) +24% on being awarded Chinese Patent No. ZL201080019566.9 entitled, devices and methods of cell capture and analysis. The9 (NASDAQ:NCTY) +17% on signing a joint venture agreement (the "JV agreement") with Shenzhen EN-plus Technologies. Eldorado Gold (NYSE:EGO) +14% on optimism over Greek snap election. Anaplan (NYSE:PLAN) +12% on Q1 earnings. Jumei International Holding (NYSE:JMEI) +12% on share repurchase. S...